Shuen-Iu Hung Selected Research

Shuen-Iu Hung Research Topics

Disease

27	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021 - 04/2004
17	Hypersensitivity (Allergy) 05/2024 - 01/2002
15	Cicatrix (Scar) 04/2024 - 03/2005
10	Drug Hypersensitivity (Drug Allergy) 01/2023 - 08/2007
9	Exanthema (Rash) 04/2024 - 02/2014
9	Neoplasms (Cancer) 04/2024 - 09/2011
8	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 03/2005
7	Drug-Related Side Effects and Adverse Reactions 04/2024 - 08/2005
7	Drug Hypersensitivity Syndrome 01/2021 - 03/2005
6	Eosinophilia 01/2019 - 02/2014
5	Necrosis 04/2024 - 12/2010
5	Gout 01/2023 - 03/2005
5	Inflammation (Inflammations) 01/2019 - 07/2002
5	Blister (Bulla) 01/2018 - 12/2008
5	Schizophrenia (Dementia Praecox) 11/2008 - 11/2005
4	Hyperuricemia 01/2016 - 03/2005
3	Acute Liver Failure (Fulminant Hepatic Failure) 01/2015 - 01/2011
2	Atopic Dermatitis (Atopic Eczema) 05/2024 - 11/2021
2	Alopecia (Baldness) 10/2023 - 01/2019
2	Infections 01/2021 - 05/2014
2	Epilepsy (Aura) 08/2020 - 04/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 09/2015
2	Wounds and Injuries (Trauma) 01/2019 - 11/2014
2	Gouty Arthritis 01/2019 - 01/2017
2	Acute Generalized Exanthematous Pustulosis 05/2014 - 09/2010
1	Asthma (Bronchial Asthma) 05/2024
1	Anaphylaxis (Anaphylactic Shock) 04/2024
1	Ovarian Neoplasms (Ovarian Cancer) 12/2023
1	Skin Abnormalities 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	COVID-19 10/2023
1	Alopecia Areata 10/2023
1	Dermatitis 02/2023
1	Mucositis 02/2023
1	Adenocarcinoma of Lung 02/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2023
1	Immediate Hypersensitivity 05/2022
1	Disseminated Intravascular Coagulation 06/2021
1	Drug Eruptions (Drug Eruption) 01/2021

Drug/Important Bio-Agent (IBA)

19	HLA-B Antigens (HLA-B)IBA 01/2021 - 04/2004
13	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020 - 04/2004
12	HLA Antigens (Human Leukocyte Antigens)IBA 04/2024 - 04/2004
9	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2002
9	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 03/2005
8	Peptides (Polypeptides)IBA 12/2023 - 03/2005
7	AntigensIBA 05/2024 - 09/2013
7	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 04/2006
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024 - 12/2011
6	Genetic Markers (Genetic Marker)IBA 04/2024 - 04/2004
5	CytokinesIBA 04/2024 - 09/2013
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2010
4	VaccinesIBA 10/2023 - 01/2018
4	EnzymesIBA 01/2023 - 11/2016
4	ChemokinesIBA 01/2023 - 09/2013
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2011
3	Immunoglobulin E (IgE)IBA 05/2024 - 11/2021
3	COVID-19 VaccinesIBA 10/2023 - 05/2022
3	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 12/2013
3	Phenytoin (Dilantin)FDA LinkGeneric 08/2020 - 08/2014
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2024 - 09/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2023
2	ZincIBA 12/2023 - 02/2023
2	Phosphotransferases (Kinase)IBA 12/2023 - 11/2014
2	ErbB Receptors (EGF Receptor)IBA 12/2023 - 02/2023
2	Excipients (Suspending Agents)IBA 10/2023 - 05/2022
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2019
2	Cytochrome P-450 CYP2C9IBA 08/2020 - 01/2019
2	abacavir (Ziagen)FDA Link 01/2020 - 08/2007
2	HLA-B57 antigenIBA 01/2020 - 11/2019
2	HLA-A31 antigenIBA 01/2020 - 02/2014
2	Febuxostat FDA Link 01/2019 - 09/2015
2	Uric Acid (Urate)IBA 01/2019 - 01/2017
2	Oxypurinol (Oxipurinol)IBA 12/2015 - 09/2015
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 08/2015 - 08/2014
2	perforin-granzyme BIBA 06/2012 - 12/2008
1	AllergensIBA 05/2024
1	Janus KinasesIBA 04/2024
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	regorafenibIBA 12/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2022
1	Polysorbates (PSML)FDA Link 05/2022
1	anti-IgE antibodiesIBA 05/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	dimethylamine (dimethylamine nitrate)IBA 11/2021
1	Filaggrin ProteinsIBA 11/2021
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 11/2021
1	ProcalcitoninIBA 06/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	micaIBA 01/2021
1	SulfonamidesIBA 01/2021

Therapy/Procedure

6	Therapeutics 12/2023 - 03/2010
5	Immunotherapy 05/2024 - 01/2018
2	Oral Administration 01/2019 - 11/2014
2	Transplantation 09/2011 - 01/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2023